Daan Gene Co., Ltd. (002030.SZ)
CNY 6.14
(-0.32%)
CNY 6.14
(-0.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 845.76 Million | 4.15 Billion | 3.3 Billion | 2.51 Billion | 92.97 Million | 392.37 Million |
| Net Income | 104.65 Million | 5.42 Billion | 3.61 Billion | 2.45 Billion | -47.15 Million | 86.51 Million |
| Depreciation & Amortization | 365.27 Million | 298.43 Million | 192.01 Million | 71.99 Million | 75.72 Million | 87.57 Million |
| Deferred income taxes | 2.32 Million | -85.65 Million | -60.21 Million | 3.27 Million | 22.92 Million | -698.08 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 317.68 Million | -2.2 Billion | -555.74 Million | 215.64 Million | -161.89 Million | 107.03 Million |
| Other non-cash items | 468.68 Million | 635.23 Million | 49.79 Million | -223.17 Million | 226.3 Million | 111.26 Million |
| Investing Cash Flow | -129.34 Million | -1.95 Billion | -1.37 Billion | -1.17 Billion | -121.07 Million | -825.51 Million |
| Investments in PPE | -572.77 Million | -1.5 Billion | -658.75 Million | -364.77 Million | -93.32 Million | -100.36 Million |
| Acquisitions | 448.92 Thousand | 762.3 Thousand | 18.77 Thousand | 4505.00 | 1600.00 | 0.83 |
| Investment purchases | -1.09 Billion | -1.43 Billion | -1.67 Billion | -2.14 Billion | -260.29 Million | -158.81 Million |
| Sales/Maturities of investments | 1.48 Billion | 1.55 Billion | 2.22 Billion | 1.33 Billion | 234.49 Million | 55.5 Million |
| Other Investing Activities | 50.19 Million | -583 Million | -1.26 Billion | 466.48 Thousand | -1.95 Million | -621.83 Million |
| Financing Cash Flow | -2.32 Billion | -1.79 Billion | -626.54 Million | -685.26 Million | -130.86 Million | -385.72 Million |
| Debt repayment | -145.36 Million | -284.34 Million | -398.75 Million | -917.38 Million | -1.22 Billion | -1.14 Billion |
| Dividends payments | -2.45 Billion | -1.55 Billion | -482.43 Million | -19.93 Million | -32.69 Million | -102.95 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -12.59 Million | 59.34 Million | 268.5 Million | 291.11 Million | 1.19 Billion | 857.36 Million |
| Accounts receivables | 1.76 Billion | -2.65 Billion | -953.22 Million | -934.41 Million | -97.69 Million | 443.21 Million |
| Accounts payables | -1.38 Billion | 649.83 Million | 645.11 Million | 1.27 Billion | -63.44 Million | -377.4 Million |
| Inventory | -61.27 Million | -112.02 Million | -187.42 Million | -131.13 Million | -23.68 Million | 41.91 Million |
| Other working capital | -1.00 | -85.65 Million | -60.21 Million | 3.27 Million | 22.92 Million | 65.11 Million |
| Cash at beginning of period | 2.59 Billion | 2.16 Billion | 870.46 Million | 227.02 Million | 385.81 Million | 1.2 Billion |
| Cash at end of period | 999.37 Million | 2.59 Billion | 2.16 Billion | 870.46 Million | 227.02 Million | 385.81 Million |
| Capital Expenditure | -572.77 Million | -1.5 Billion | -658.75 Million | -364.77 Million | -93.32 Million | -100.36 Million |
| Effect of forex changes on cash | 2.25 Million | 27.52 Million | -3.24 Million | -9.93 Million | 179.38 Thousand | 603.62 Thousand |
| Net cash flow / Change in cash | -1.59 Billion | 427.93 Million | 1.29 Billion | 643.43 Million | -158.78 Million | -818.25 Million |
| Free Cash Flow | 272.99 Million | 2.65 Billion | 2.64 Billion | 2.14 Billion | -353.8 Thousand | 292.01 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -103.5 Million | -35.92 Million | -363.29 Million | 104.65 Million | -247.93 Million | -50.16 Million |
| Depreciation & Amortization | - | 90.55 Million | 90.55 Million | 365.27 Million | 96.15 Million | -168.6 Million |
| Deferred income taxes | - | - | - | 2.32 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 156.05 Million | - | 317.68 Million | 1.7 Billion | -1.03 Billion |
| Other non-cash items | 216.37 Million | 256.06 Million | 273.83 Million | 468.68 Million | -1.04 Billion | 1.57 Billion |
| Investing Cash Flow | -127.17 Million | 45.68 Million | -102.11 Million | -129.34 Million | -487.92 Million | -147.46 Million |
| Investments in PPE | -16.15 Million | -6.02 Million | -71.89 Million | -572.77 Million | -264.04 Million | -40.18 Million |
| Acquisitions | 54.52 Thousand | - | 32 Thousand | 448.92 Thousand | 440.73 Thousand | -11.06 |
| Investment purchases | 28.93 Million | -262.31 Million | -67.81 Million | -1.09 Billion | -124.82 Million | -90.24 Million |
| Sales/Maturities of investments | -120 Million | 214.01 Million | 137.55 Million | 1.48 Billion | 150.16 Million | 74.93 Million |
| Other Investing Activities | -19.99 Million | 100 Million | -100 Million | 50.19 Million | -249.66 Million | -91.97 Million |
| Financing Cash Flow | 32.88 Million | -217.21 Million | -7.69 Million | -2.32 Billion | -27.98 Million | -32.1 Million |
| Debt repayment | -11.54 Million | -184.34 Million | -14.16 Million | -145.36 Million | -11.61 Million | -44.22 Million |
| Dividends payments | - | -24.08 Million | -2.31 Million | -2.45 Billion | -2.45 Billion | -2.4 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 44.42 Million | -32.87 Million | 6.47 Million | -12.59 Million | 2.43 Billion | 14.52 Million |
| Accounts receivables | - | 174.59 Million | - | 1.76 Billion | 1.76 Billion | -1.08 Billion |
| Accounts payables | - | - | - | -1.38 Billion | - | - |
| Inventory | - | -18.53 Million | - | -61.27 Million | -61.27 Million | 54.41 Million |
| Other working capital | - | - | - | -1.00 | - | - |
| Cash at beginning of period | 756.26 Million | 798.47 Million | 999.37 Million | 2.59 Billion | 1 Billion | 866.21 Million |
| Cash at end of period | 773.44 Million | 756.26 Million | 798.47 Million | 999.37 Million | 999.37 Million | 1 Billion |
| Capital Expenditure | -16.15 Million | -6.02 Million | -71.89 Million | -572.77 Million | -264.04 Million | -40.18 Million |
| Effect of forex changes on cash | - | 316.78 Thousand | 55.97 Thousand | 2.25 Million | -4.11 Million | -5.3 Million |
| Net cash flow / Change in cash | 17.17 Million | -42.2 Million | -200.89 Million | -1.59 Billion | -5.17 Million | 137.73 Million |
| Free Cash Flow | 96.71 Million | 123.55 Million | -161.35 Million | 272.99 Million | 241.31 Million | 282.42 Million |
ARKA
SRCH
002848
5071
0VHA
000910